Blood-based Biomarkers Identified for Detecting Glioma
Biomarkers, or ‘biological markers’, are used to indicate biological processes by measuring specific characteristics. In this study, biomarkers would ideally be used to inform the medical team to the presence […]
brainstrust Gains PIF TICK Accreditation to Become a ‘Trusted Information Creator’
We are pleased to announce that brainstrust has been awarded the PIF TICK – the UK’s only quality mark for print and online health information. The PIF TICK, which launched in […]
COVID-19 Spring Booster Programme – What Does this Mean for People with a Brain Tumour?
The NHS recently announced its plans for the COVID-19 Spring booster programme, with invites being sent out now to those who are eligible. So, who is eligible and what does […]
brainstrust’s Peer Support Scheme Launch
Our support doesn’t end at the end of Brain Tumour Awareness Month, and we’re always striving to make sure that we provide you with the best support possible to help […]
A Devastating Loss for Our Community
Rest in Peace Tom Parker We are so very sad this morning to hear of the passing of Tom Parker yesterday. Our thoughts are with Tom’s family, friends and fans. […]
10-Year Cancer Plan: One Cancer Voice Consensus Statement
Today, alongside 53 other cancer charities, we are speaking with One Cancer Voice and publishing 10 tests that the new 10-year Cancer Plan must meet if it is to be […]
Funding Boost for Early Phase Clinical Trials
A funding boost for early phase clinical trials has been announced by the NIHR (National Institute of Health Research. Now – this may seem remote from clinical research which focuses […]
Jack Jarvis Completes World First Row For brainstrust
“If my Grandad could battle a brain tumour for 2 years, there’s no reason I can’t battle the Atlantic for 3 months” British soldier Jack Jarvis has officially become […]
Clinical Study Investigates Use of Temozolomide for Anaplastic Astrocytomas
An international group of researchers have collaborated to investigate alternative treatment options for those with anaplastic astrocytoma as a part of the ‘CATNON’ trial. The results have been published by […]
Potential Improvements Found For Cell-Based Immunotherapy Treatment
A research team at Yale university are investigating ways to improve a type of treatment known as CAR-T therapy. The treatment involves reprogramming the patient’s own immune system cells to […]